Photo of Shane Reeves
R Tennessee Senate · District 14

Sen. Shane Reeves

Compare
Total votes
21,309
all sessions
Attendance
98%
268 missed
Lower than 94% of chamber peers
With party
99%
of cast votes
Near the chamber average
Bipartisan score
0%
crosses aisle rarely
Near the chamber average
Sponsored
688
bills & resolutions
Near the chamber average
Committees
3
assignments
688 bills and resolutions

Sponsored bills

Total
688
Primary
688
Co-sponsor
0
This page
688
matching current filters
Primary SB 2139
Signed into law · Tennessee Senate · Lead sponsor
Pharmacy, Pharmacists - As enacted, authorizes the board of pharmacy to register any mechanical or electronic systems that operate solely on the premises of a hematology or oncology clinic in this state and that perform the storage, control, and dispensing of commercially available drug products pursuant to a valid patient-specific prescription, as part of the operations of a licensed pharmacy; makes related changes. - Amends TCA Title 29; Title 53; Title 56; Title 63; Title 68 and Title 71.

Maddy summaryThis bill allows licensed pharmacies in Tennessee to register and operate automated systems that store, control, and dispense prescription drugs exclusively within hematology or oncology clinics. The legislation specifically enables approved pharmacies to inspect, restock, and re-dispense unopened, unused specialty medications that are returned from healthcare facilities by providers. To ensure safety, pharmacists must verify that returned drugs remain in their original, unopened packaging before they can be reused, and the pharmacy must provide financial credit or reimbursement to the entity that originally paid for the medication. Additionally, the law outlines specific record-keeping requirements for these transactions and establishes liability protections for pharmacists and manufacturers acting in good faith during the restocking process.

Signed into law May 13, 2024 0 co-sponsors
Primary SB 1397
Signed into law · Tennessee Senate · Lead sponsor
Regional Authorities and Special Districts - As enacted, makes revisions to the law relative to the Tennessee Duck River Development Agency. - Amends TCA Title 64, Chapter 1, Part 6.

Maddy summaryThis bill updates the laws governing the Tennessee Duck River Development Agency to establish a new fee system for water withdrawals. It defines "participating entities" as any group or business that takes water from the Duck River or its specific tributaries in four counties and requires a state permit. Under the new rules, these entities must pay a per-thousand-gallon withdrawal fee, which is calculated based on how much water they use and must be approved by an advisory committee. The collected funds are intended to cover the agency's operating costs and finance regional water supply projects, with the fee amount reviewed at least every two years.

Signed into law May 13, 2024 0 co-sponsors
Primary SB 2022
Signed into law · Tennessee Senate · Lead sponsor
Health Care - As enacted, makes revisions to law relative to the health facilities commission; makes related changes. - Amends TCA Title 4; Title 63; Title 68 and Title 71.

Maddy summaryThis law requires temporary healthcare staffing agencies operating in Tennessee to register with the state's Health Facilities Commission by December 31 each year. The registration process asks these agencies to submit their business name and the names of any individuals who control the company. Once signed into effect, this rule applies to all such agencies currently doing business in the state. The change aims to improve oversight by ensuring the commission has current information about staffing providers.

Signed into law May 13, 2024 0 co-sponsors
Primary SB 2019
Signed into law · Tennessee Senate · Lead sponsor
Drugs, Prescription - As enacted, makes changes to the law relative to prescribing buprenorphine products. - Amends TCA Title 33 and Title 53.

Maddy summaryThis law updates Tennessee's rules for doctors who prescribe buprenorphine, a medication used to treat opioid addiction. It clarifies which types of clinics are allowed to offer this treatment and sets new requirements for how the medication must be prescribed. Specifically, the bill expands the number of patients a doctor can treat without extra paperwork from 50 to 100 and increases the number of patients who can be treated in a non-residential setting from four to ten. Additionally, it requires that buprenorphine be given with naloxone, an overdose-reversal drug, unless the patient is pregnant or has a known allergy to naloxone. These changes aim to make it easier for healthcare providers to manage opioid use disorder while maintaining safety standards.

Signed into law May 9, 2024 0 co-sponsors
Primary SB 2813
Signed into law May 9, 2024 0 co-sponsors
Primary SB 2017
Passed May 1, 2024 0 co-sponsors
Primary SB 2011
Passed May 1, 2024 0 co-sponsors
Primary SB 688
Passed Apr 29, 2024 0 co-sponsors
Showing 121 to 130 of 688 bills
Previous 1 … 12 13 14 … 69 Next